Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
Myxothiazol (AB-Mx f16-1), a new antifungal antibiotic, is produced by the myxobacterium Myxococcus fulvus strain Mx f16. It is active against many filamentous fungi, and completely inhibits growth of Mucor hiemalis at a concentration of 2 micrograms/ml. The molecular formula of myxothiazol was determined to e C25H33N3O3S2.
D000818:Animals; D000935:Antifungal Agents / Q000096:biosynthesis* / Q000302:isolation & purification / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D002627:Chemistry, Physical; D002642:Chick Embryo; D004352:Drug Resistance, Microbial; D005285:Fermentation; D005658:Fungi / Q000187:drug effects; D008689:Methacrylates; D051379:Mice; D009231:Myxococcales / Q000378:metabolism*; D013844:Thiazoles / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology
D000935:Antifungal Agents; D008689:Methacrylates; D013844:Thiazoles; C030517:myxothiazol